Detalles de la búsqueda
1.
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes.
BMC Infect Dis
; 23(1): 91, 2023 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36782125
2.
Switching to Dolutegravir/Lamivudine Two-Drug Regimen: Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care.
HIV AIDS (Auckl)
; 16: 133-140, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38645753
3.
Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
Dermatol Surg
; 38(7 Pt 2): 1193-205, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22759256
4.
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease risk.
AIDS
; 36(14): 1997-2003, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35876637
5.
Placental pathology and fetal demise at 35 weeks of gestation in a woman with SARS-CoV-2 infection: A case report.
Case Rep Womens Health
; 30: e00289, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527073
6.
Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression.
J Neurol Neurosurg Psychiatry
; 81(3): 247-54, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19828476
7.
Seven-year follow-up on lopinavir/ ritonavir monotherapy.
J Int Assoc Physicians AIDS Care (Chic)
; 8(3): 191-2, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19414830
8.
Two-drug antiretroviral regimens: an assessment of virologic response and durability among treatment-experienced persons living with HIV in the OPERA® Observational Database.
J Int AIDS Soc
; 22(12): e25418, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802641
9.
Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients.
AIDS
; 21(6): F11-8, 2007 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17413685
10.
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients.
AIDS Res Hum Retroviruses
; 23(2): 216-23, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17263650
11.
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice.
Clin Drug Investig
; 37(1): 51-60, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27587070
12.
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial.
Clin Infect Dis
; 43(10): 1337-46, 2006 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17051503
13.
The safety and tolerability of Z-100 in patients infected with HIV-1.
Antivir Ther
; 11(3): 297-303, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16759045
14.
A pilot study of switch to lopinavir/ritonavir (LPV/r) monotherapy from nonnucleoside reverse transcriptase inhibitor-based therapy.
HIV Clin Trials
; 7(5): 237-45, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17162317
15.
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial.
Ann Intern Med
; 139(5 Pt 1): 313-20, 2003 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-12965939
16.
Treating morphologic and metabolic complications in HIV-infected patients on antiretroviral therapy. A consensus statement of an advisory committee of the International Association of Physicians in AIDS Care.
IAPAC Mon
; 11(2): 38-46, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15971353
17.
Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.
Antivir Ther
; 7(3): 199-209, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12487388
18.
Successful use of a tipranavir/ritonavir-based antiretroviral regimen following development of viral resistance to darunavir.
HIV Clin Trials
; 9(2): 140-1, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18474499
19.
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51).
J Acquir Immune Defic Syndr
; 47(4): 429-40, 2008 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18176328
20.
An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen.
AIDS Patient Care STDS
; 22(4): 263-6, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18422459
Resultados
1 -
20
de 20
1
Próxima >
>>